Disease-Modifying Medical and Cell-Based Therapy 383serum levels of IL-6, IL-10, MMP-1 and MMP-
3 in patients with resistant rheumatoid arthritis.
Cytokine 2006;33:106–110.
Lotz M. The role of nitric oxide in articular cartilage
damage. Rheum Dis Clin North Am 1999;25:269–
282.
Lu HT, Sheu MT, Lin YF,et al.Injectable hyaluronic-
acid-doxycycline hydrogel therapy in experimen-
tal rabbit osteoarthritis. BMC Vet Res 2013;9:
68.
Marder W, McCune WJ. Advances in immunosup-
pressive therapy. Semin Respir Crit Care Med
2007;28:398–417.
Meier FMP, Frerix M, Herrman W, et al. Cur-
rent immunotherapy in rheumatoid arthritis.
Immunotherapy 2013;5:955–974.
Muir P, Oldenhoff WE, Hudson AP,et al.Detection of
DNA from a range of bacterial species in the knee
joints of dogs with inflammatory knee arthritis and
associated degenerative anterior cruciate ligament
rupture. Microb Pathog 2007;42:47–55.
Muir P, Schwartz Z, Malek S,et al.Contralateral
cruciate survival in dogs with unilateral non-
contact cranial cruciate ligament rupture. PLoS
One 2011a;6:e25331.
Muir P, Kelly JL, Marvel SJ,et al.Lymphocyte popula-
tions in joint tissues from dogs with inflammatory
stifle arthritis and associated degenerative cranial
cruciate ligament rupture. Vet Surg 2011b;40:753–
761.
Muir P, Hans EC, Racette M,et al.Autologous
bone marrow-derived mesenchymal stem cells
modulate molecular markers of inflammation in
dogs with cruciate ligament rupture. PLoS One
2016;11:e0159095.
Nielen AL, Janss LL, Knol BW. Heritability estima-
tions for diseases, coat color, body weight, and
height in a birth cohort of Boxers. Am J Vet Res
2001;62:1198–1206.
Reinders MEJ, De Fijter JW, Roelofs H,et al.Autolo-
gous bone marrow-derived mesenchymal stromal
cells for the treatment of allograft rejection after
renal transplantation: results of a phase I study.
Stem Cells Transl Med 2013;2:107–111.
Smith GN Jr, Brandt KD, Hasty KA. Activation of
recombinant human neutrophil procollagenase in
the presence of doxycycline results in fragmenta-
tion of the enzyme and loss of enzyme activity.
Arthritis Rheum 1996;39:235–244.
Smith GN Jr, Yu LP, Jr, Brandt KD,et al. Oral
administration of doxycycline reduces collagenase
and gelatinase activities in extracts of human
osteoarthritic cartilage. J Rheumatol 1998;25:532–
535.
Straub RH, Cutolo M. Glucocorticoids and chronic
inflammation. Rheumatology (Oxford) 2016;55:ii6–
ii14.
Viviano KR. Update on immunosuppressive thera-
pies for dogs and cats. Vet Clin North Am Small
Anim Pract 2013;43:1149–1170.
von Pfiel DJF, Sung J, Barry J,et al.Effect of doxy-
cycline on contralateral canine cranial cruciate lig-
ament rupture. A prospective randomized clini-
cal trial in 69 dogs. Vet Comp Orthop Traumatol
2015;28:371–378.
Waterman RS, Tomchuck SL, Henkle SL,et al.A
new mesenchymal stem cell (MSC) paradigm:
Polarization into a pro-inflammatory MSC1 or an
immunosuppressive MSC2 phenotype. PLoS One
2010;5:e10088.
Wilke VL, Conzemius MG, Kinghorn BP,et al.Inher-
itance of rupture of the cranial cruciate ligament in
Newfoundlands. J Am Vet Med Assoc 2006;228:61–
64.
Yu LP Jr, Smith GN Jr, Brandt KD,et al.Reduction of
the severity of canine osteoarthritis by prophylactic
treatment with oral doxycycline. Arthritis Rheum
1992;35:1150–1159.
Yu LP Jr, Smith GN Jr, Hasty KA,et al.Doxycycline
inhibits type XI collagenolytic activity of extracts
from human osteoarthritic cartilage and of gelati-
nase. J Rheumatol 1991;18:1450–1452.